Catalyst Wire Dossier Catalyst Wire Dossier

ONTRUZANT

TRASTUZUMAB · Organon LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ONTRUZANT, covering 2019-01-18 to 2026-04-15. Get the full timeline:

Most recent: FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)

See pricing